Epithelial‑derived head and neck squamous tumourigenesis (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8800
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2024 AND VI 52 AND IP 4
Results: 18
1
2
[Retracted] MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8799
- By:
- Publication type:
- Article
3
Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8798
- By:
- Publication type:
- Article
4
[Corrigendum] DJ‑1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8797
- By:
- Publication type:
- Article
5
A potential mechanism of tumor immune escape: Regulation and application of soluble natural killer group 2 member D ligands (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8796
- By:
- Publication type:
- Article
6
[Retracted] MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8795
- By:
- Publication type:
- Article
7
Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8794
- By:
- Publication type:
- Article
8
[Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial‑to‑mesenchymal transition via suppressing the ROS/ERK/Slug/E‑cadherin pathway.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8793
- By:
- Publication type:
- Article
9
Histone deacetylase inhibitor and PD‑1 blockade synergistically inhibit B‑cell lymphoma progression in mice model by promoting T‑cell infiltration and apoptosis.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8792
- By:
- Publication type:
- Article
10
[Corrigendum] Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt‑NF‑κB signaling.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8787
- By:
- Publication type:
- Article
11
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8791
- By:
- Publication type:
- Article
12
DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8790
- By:
- Publication type:
- Article
13
[Retracted] LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑HSPA9.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8789
- By:
- Publication type:
- Article
14
Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8788
- By:
- Publication type:
- Article
15
Emerging role of sirtuins in non‑small cell lung cancer (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8786
- By:
- Publication type:
- Article
16
[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8785
- By:
- Publication type:
- Article
17
Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8784
- By:
- Publication type:
- Article
18
[Corrigendum] Enhanced antitumor activity by the combination of dasatinib and combretastatin A‑4 in vitro and in vivo.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8783
- By:
- Publication type:
- Article